Details for: RPS17
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 63.01rCSI 50.03%PRS 17.39
-
CSI 61.87rCSI 49.56%PRS 17.96
-
CSI 54.93rCSI 44.42%PRS 9.77
-
CSI 44.1rCSI 38.73%PRS 11.12
-
CSI 42.63rCSI 36.91%PRS 11.01
-
CSI 41.6rCSI 29.86%PRS 13.45
-
CSI 39.05rCSI 35.27%PRS 8.75
-
CSI 38.52rCSI 37.88%PRS 10.76
-
CSI 32.6rCSI 34.16%PRS 10.55
-
CSI 32.44rCSI 26.21%PRS 17.87
-
CSI 32.04rCSI 61.16%PRS 23.56
-
CSI 31.51rCSI 56.88%PRS 27.33
-
CSI 31.05rCSI 23.93%PRS 8.95
-
CSI 30.8rCSI 73.22%PRS 14.86
-
CSI 30.06rCSI 37.19%PRS 8.68
-
CSI 29.27rCSI 36.73%PRS 12.63
-
CSI 27.81rCSI 23.32%PRS 11.84
-
CSI 27.47rCSI 42.45%PRS 9.27
-
CSI 27.06rCSI 17.99%PRS 11.8
-
CSI 26.8rCSI 32.37%PRS 11.63
-
CSI 26.76rCSI 38.6%PRS 13.79
-
CSI 26.45rCSI 31.07%PRS 11.72
-
CSI 25.09rCSI 40.46%PRS 15.83
-
CSI 24.01rCSI 32.82%PRS 11.23
-
CSI 23.2rCSI 16.29%PRS 26.92
-
CSI 22.94rCSI 66.36%PRS 22.15
-
CSI 22.65rCSI 38.81%PRS 13.26
-
CSI 22.47rCSI 18.76%PRS 30.01
-
CSI 22.46rCSI 17.67%PRS 11.75
-
CSI 22rCSI 17.39%PRS 6.81
-
CSI 21.35rCSI 15.86%PRS 14.75
-
CSI 21.23rCSI 18.67%PRS 7.18
-
CSI 21.06rCSI 24.11%PRS 20.37
-
CSI 20.97rCSI 32.7%PRS 24.23
-
CSI 20.46rCSI 20.21%PRS 39.41
-
CSI 19.81rCSI 54.43%PRS 16.43
-
CSI 19.67rCSI 16.87%PRS 19.02
-
CSI 18.75rCSI 15.53%PRS 9.9
-
CSI 18.2rCSI 66.17%PRS 40.34
-
CSI 17.74rCSI 35.61%PRS 7.32
-
CSI 17.36rCSI 38.44%PRS 9.18
-
CSI 16.9rCSI 14.8%PRS 13.19
-
CSI 16.85rCSI 12.66%PRS 10.23
-
CSI 16.77rCSI 23.3%PRS 10.22
-
CSI 16.71rCSI 17.45%PRS 30.44
-
CSI 15.99rCSI 20.95%PRS 13.85
-
CSI 15.72rCSI 24.01%PRS 9.91
-
CSI 15.67rCSI 29.59%PRS 12.28
-
CSI 15.56rCSI 21.27%PRS 16.58
-
CSI 15.55rCSI 13.08%PRS 16.19
-
CSI 15.16rCSI 53.18%PRS 17.94
-
CSI 15.12rCSI 11.34%PRS 28.65
-
CSI 15.1rCSI 14.05%PRS 9.96
-
CSI 15.08rCSI 23.18%PRS 14.14
-
CSI 14.92rCSI 11.35%PRS 12.97
-
CSI 14.73rCSI 10.91%PRS 8.89
-
CSI 14.55rCSI 11.01%PRS 13.74
-
CSI 14.55rCSI 17.47%PRS 9.77
-
CSI 14.55rCSI 18.28%PRS 45.43
-
CSI 14.53rCSI 18.59%PRS 41.2
-
CSI 14.46rCSI 9.63%PRS 26.42
-
CSI 14.13rCSI 17.41%PRS 32.34
-
CSI 14.05rCSI 19.91%PRS 9.28
-
CSI 13.79rCSI 25.27%PRS 45.76
-
CSI 13.78rCSI 30.19%PRS 13.32
-
CSI 13.58rCSI 20.19%PRS 12.2
-
CSI 13.51rCSI 7.98%PRS 13.65
-
CSI 13.41rCSI 17.95%PRS 44.04
-
CSI 13.34rCSI 16.61%PRS 14.18
-
CSI 13.07rCSI 13.69%PRS 9.2
-
CSI 12.99rCSI 13.16%PRS 53.33
-
CSI 12.69rCSI 9.47%PRS 16.66
-
CSI 12.62rCSI 24.54%PRS 10.08
-
CSI 12.57rCSI 12.35%PRS 28.64
-
CSI 12.46rCSI 16.97%PRS 24.13
-
CSI 12.43rCSI 35.34%PRS 12.22
-
CSI 12.4rCSI 14.32%PRS 8.75
-
CSI 12.4rCSI 18.96%PRS 16.07
-
CSI 12.32rCSI 57.78%PRS 26.78
-
CSI 12.27rCSI 41.47%PRS 16.84
-
CSI 12.15rCSI 41.84%PRS 38.77
-
CSI 12.1rCSI 14.21%PRS 62.23
-
CSI 12.04rCSI 33.19%PRS 9.59
-
CSI 11.97rCSI 24.84%PRS 9.86
-
CSI 11.97rCSI 11.52%PRS 10.21
-
CSI 11.97rCSI 15.91%PRS 10.78
-
CSI 11.9rCSI 19%PRS 10.78
-
CSI 11.84rCSI 26.07%PRS 10.89
-
CSI 11.28rCSI 25.6%PRS 13.82
-
CSI 11.09rCSI 56.87%PRS 41.17
-
CSI 10.94rCSI 17.91%PRS 7.68
-
CSI 10.71rCSI 7.21%PRS 11.86
-
CSI 10.61rCSI 13.62%PRS 9.62
-
CSI 10.33rCSI 15.75%PRS 9.27
-
CSI 10.13rCSI 10.42%PRS 16.08
-
CSI 9.91rCSI 10.53%PRS 17.6
-
CSI 9.89rCSI 6.91%PRS 10.43
-
CSI 9.87rCSI 7.39%PRS 16.06
-
CSI 9.86rCSI 16.84%PRS 20.12
-
CSI 9.86rCSI 18.99%PRS 22.24
-
CSI -18.4rCSI -35.1%PRS 15.9%
-
CSI -17.3rCSI -45.0%PRS 9.7%
-
CSI -4.2rCSI -10.1%PRS 12.7%
-
CSI -2.8rCSI -3.2%PRS 13.9%
-
CSI -1.8rCSI -14.2%PRS 10.6%
-
CSI -1.7rCSI -3.0%PRS 8.3%
-
CSI -0.3rCSI -3.6%PRS 14.5%
-
CSI 0.1rCSI 2.4%PRS 48.8%
-
CSI 0.3rCSI 1.1%PRS 23.1%
-
CSI 0.3rCSI 0.6%PRS 20.1%
-
CSI 0.3rCSI 5.0%PRS 59.6%
-
CSI 0.5rCSI 0.5%PRS 10.0%
-
CSI 0.5rCSI 2.8%PRS 40.1%
-
CSI 0.5rCSI 7.5%PRS 79.5%
-
CSI 0.5rCSI 4.5%PRS 19.5%
-
CSI 0.7rCSI 3.7%PRS 32.7%
-
CSI 0.7rCSI 6.1%PRS 43.1%
-
CSI 0.7rCSI 15.3%PRS 82.5%
-
CSI 0.8rCSI 5.6%PRS 27.2%
-
CSI 0.9rCSI 18.2%PRS 52.0%
-
CSI 0.9rCSI 2.2%PRS 10.2%
-
CSI 0.9rCSI 3.8%PRS 26.0%
-
CSI 0.9rCSI 1.6%PRS 9.3%
-
CSI 0.9rCSI 2.6%PRS 8.0%
-
CSI 0.9rCSI 5.7%PRS 32.4%
-
CSI 0.9rCSI 2.7%PRS 19.5%
-
CSI 1.0rCSI 19.3%PRS 32.5%
-
CSI 1.0rCSI 0.8%PRS 9.4%
-
CSI 1.0rCSI 1.5%PRS 7.9%
-
CSI 1.1rCSI 1.1%PRS 10.5%
-
CSI 1.1rCSI 2.4%PRS 11.2%
-
CSI 1.2rCSI 18.0%PRS 31.8%
-
CSI 1.3rCSI 7.3%PRS 14.6%
-
CSI 1.3rCSI 5.9%PRS 9.8%
-
CSI 1.4rCSI 7.8%PRS 38.3%
-
CSI 1.4rCSI 4.4%PRS 28.9%
-
CSI 1.4rCSI 7.6%PRS 18.2%
-
CSI 1.5rCSI 36.4%PRS 66.4%
-
CSI 1.5rCSI 2.4%PRS 12.8%
-
CSI 1.5rCSI 1.9%PRS 10.5%
-
CSI 1.6rCSI 12.7%PRS 10.3%
-
CSI 1.6rCSI 16.3%PRS 62.8%
-
CSI 1.6rCSI 10.8%PRS 57.1%
-
CSI 1.6rCSI 2.6%PRS 7.6%
-
CSI 1.7rCSI 19.1%PRS 38.7%
-
CSI 1.7rCSI 7.5%PRS 35.6%
-
CSI 1.7rCSI 4.2%PRS 7.6%
-
CSI 1.7rCSI 10.2%PRS 22.3%
-
CSI 1.7rCSI 11.5%PRS 10.8%
-
CSI 1.7rCSI 6.3%PRS 17.0%
-
CSI 1.7rCSI 4.5%PRS 16.5%
-
CSI 1.8rCSI 2.5%PRS 11.2%
-
CSI 1.8rCSI 4.6%PRS 30.3%
-
CSI 1.9rCSI 20.8%PRS 18.0%
-
CSI 1.9rCSI 36.8%PRS 62.3%
-
CSI 2.0rCSI 2.0%PRS 8.5%
-
CSI 2.1rCSI 4.9%PRS 12.2%
-
CSI 2.1rCSI 54.7%PRS 47.4%
-
CSI 2.2rCSI 18.6%PRS 52.6%
-
CSI 2.2rCSI 5.8%PRS 28.3%
-
CSI 2.3rCSI 3.4%PRS 9.3%
-
CSI 2.3rCSI 16.4%PRS 31.0%
-
CSI 2.3rCSI 3.2%PRS 15.2%
-
CSI 2.5rCSI 6.2%PRS 10.0%
-
CSI 2.5rCSI 6.4%PRS 13.7%
-
CSI 2.5rCSI 24.5%PRS 36.4%
-
CSI 2.5rCSI 13.5%PRS 24.9%
-
CSI 2.5rCSI 56.8%PRS 46.1%
-
CSI 2.5rCSI 14.2%PRS 31.4%
-
CSI 2.5rCSI 2.6%PRS 14.1%
-
CSI 2.5rCSI 3.8%PRS 11.3%
-
CSI 2.5rCSI 25.0%PRS 30.0%
-
CSI 2.6rCSI 12.9%PRS 12.9%
-
CSI 2.6rCSI 17.0%PRS 25.8%
-
CSI 2.6rCSI 5.8%PRS 15.1%
-
CSI 2.6rCSI 4.0%PRS 17.3%
-
CSI 2.7rCSI 3.9%PRS 10.5%
-
CSI 2.7rCSI 41.1%PRS 24.7%
-
CSI 2.7rCSI 4.7%PRS 10.0%
-
CSI 2.9rCSI 5.9%PRS 10.2%
-
CSI 2.9rCSI 4.0%PRS 10.3%
-
CSI 3.0rCSI 14.1%PRS 13.5%
-
CSI 3.0rCSI 9.7%PRS 11.0%
-
CSI 3.1rCSI 6.9%PRS 10.4%
-
CSI 3.1rCSI 78.3%PRS 32.8%
-
CSI 3.1rCSI 54.6%PRS 39.7%
-
CSI 3.2rCSI 7.3%PRS 8.9%
-
CSI 3.2rCSI 42.3%PRS 32.7%
-
CSI 3.2rCSI 7.7%PRS 15.6%
-
CSI 3.2rCSI 30.8%PRS 42.2%
-
CSI 3.3rCSI 12.7%PRS 14.7%
-
CSI 3.3rCSI 78.0%PRS 34.9%
-
CSI 3.3rCSI 4.9%PRS 13.0%
-
CSI 3.4rCSI 4.6%PRS 10.9%
-
CSI 3.4rCSI 9.0%PRS 9.0%
-
CSI 3.4rCSI 3.2%PRS 10.3%
-
CSI 3.4rCSI 14.8%PRS 17.9%
-
CSI 3.4rCSI 5.5%PRS 8.5%
-
CSI 3.4rCSI 15.8%PRS 21.0%
-
CSI 3.5rCSI 80.6%PRS 60.7%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1985324850
Symbol: RS17_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 3529092
Title: Homologous ribosomal proteins in bacteria, yeast, and humans.
PubMed ID: 3529092
PubMed ID: 3240863
Title: The transcriptionally active human ribosomal protein S17 gene.
PubMed ID: 3240863
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 16572171
Title: Analysis of the DNA sequence and duplication history of human chromosome 15.
PubMed ID: 16572171
DOI: 10.1038/nature04601
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 8706699
Title: Characterization of the human small-ribosomal-subunit proteins by N-terminal and internal sequencing, and mass spectrometry.
PubMed ID: 8706699
PubMed ID: 17647292
Title: Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia.
PubMed ID: 17647292
DOI: 10.1002/humu.20608
PubMed ID: 19061985
Title: Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients.
PubMed ID: 19061985
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19369195
Title: Large-scale proteomics analysis of the human kinome.
PubMed ID: 19369195
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24524803
Title: A new system for naming ribosomal proteins.
PubMed ID: 24524803
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25114211
Title: Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
PubMed ID: 25114211
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
PubMed ID: 28112733
Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
PubMed ID: 28112733
DOI: 10.1038/nsmb.3366
PubMed ID: 36638793
Title: An E3 ligase network engages GCN1 to promote the degradation of translation factors on stalled ribosomes.
PubMed ID: 36638793
PubMed ID: 23636399
Title: Structures of the human and Drosophila 80S ribosome.
PubMed ID: 23636399
DOI: 10.1038/nature12104
PubMed ID: 34516797
Title: Nucleolar maturation of the human small subunit processome.
PubMed ID: 34516797
Sequence Information:
- Length: 135
- Mass: 15550
- Checksum: 299AD605C5401325
- Sequence:
MGRVRTKTVK KAARVIIEKY YTRLGNDFHT NKRVCEEIAI IPSKKLRNKI AGYVTHLMKR IQRGPVRGIS IKLQEEERER RDNYVPEVSA LDQEIIEVDP DTKEMLKLLD FGSLSNLQVT QPTVGMNFKT PRGPV